ZA899113B - Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon - Google Patents

Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Info

Publication number
ZA899113B
ZA899113B ZA899113A ZA899113A ZA899113B ZA 899113 B ZA899113 B ZA 899113B ZA 899113 A ZA899113 A ZA 899113A ZA 899113 A ZA899113 A ZA 899113A ZA 899113 B ZA899113 B ZA 899113B
Authority
ZA
South Africa
Prior art keywords
cell carcinoma
squamous cell
recombinant human
intralesionally
treatment
Prior art date
Application number
ZA899113A
Other languages
English (en)
Inventor
Daniel J Tanner
J Tanner Daniel
Edwin A Peets
A Peets Edwin
Kenneth A Smiles
A Smiles Kenneth
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of ZA899113B publication Critical patent/ZA899113B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA899113A 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon ZA899113B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27831588A 1988-12-01 1988-12-01

Publications (1)

Publication Number Publication Date
ZA899113B true ZA899113B (en) 1990-08-29

Family

ID=23064525

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA899113A ZA899113B (en) 1988-12-01 1989-11-29 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon

Country Status (14)

Country Link
EP (2) EP0446279A1 (fr)
JP (1) JPH0647556B2 (fr)
KR (1) KR950011889B1 (fr)
AT (1) ATE92333T1 (fr)
AU (1) AU634511B2 (fr)
CA (1) CA2004202C (fr)
DE (1) DE68908119T2 (fr)
DK (1) DK103891D0 (fr)
ES (1) ES2058555T3 (fr)
IE (1) IE63121B1 (fr)
IL (1) IL92495A (fr)
MY (1) MY107071A (fr)
WO (1) WO1990006135A1 (fr)
ZA (1) ZA899113B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563177A1 (fr) * 1990-12-14 1993-10-06 Schering Corporation Administration orale d'interferon alpha pour traiter les tumeurs malignes des poumons
IL100415A0 (en) * 1990-12-21 1992-09-06 Schering Corp Administering alpha interferon by oral inhalation to treat asthma and non-malignant proliferative pulmonary diseases
US7294332B2 (en) 1995-10-04 2007-11-13 Schering Corporation Combination therapy (temozolomide and α-IFN) for advanced cancer
CA2233544A1 (fr) * 1995-10-04 1997-04-10 Schering Corporation Combinaison temozolomide et interferon alpha pour le traitement du cancer avance

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0077063B1 (fr) * 1981-10-13 1988-03-16 Exovir, Inc. Compositions contenant de l'interféron et application de ces compositions dans le traitement des infections herpétiques, lésions prémalignes de la peau, malignités de la peau et psoriasis
AU601741B2 (en) * 1986-05-27 1990-09-20 Schering Corporation Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon

Also Published As

Publication number Publication date
EP0446279A1 (fr) 1991-09-18
EP0372809B1 (fr) 1993-08-04
DE68908119D1 (de) 1993-09-09
JPH04500678A (ja) 1992-02-06
IL92495A (en) 1995-05-26
AU634511B2 (en) 1993-02-25
KR900701311A (ko) 1990-12-01
DK103891A (da) 1991-05-31
EP0372809A1 (fr) 1990-06-13
ES2058555T3 (es) 1994-11-01
WO1990006135A1 (fr) 1990-06-14
CA2004202C (fr) 2001-02-13
JPH0647556B2 (ja) 1994-06-22
CA2004202A1 (fr) 1990-06-01
DE68908119T2 (de) 1993-11-18
MY107071A (en) 1995-09-30
KR950011889B1 (ko) 1995-10-12
IL92495A0 (en) 1990-08-31
DK103891D0 (da) 1991-05-31
IE63121B1 (en) 1995-03-22
ATE92333T1 (de) 1993-08-15
IE893828L (en) 1990-06-01
AU4802590A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
NO176665C (no) Fremgangsmåte for fremstilling av ikke-glykosylert IL-6 og vektor for utskillelse derav
NZ212632A (en) Tumor necrosis factor, its preparation and its use
GB8805792D0 (en) Medicaments
PH23901A (en) Treatment of diabetes using fluoxetine
ATE109765T1 (de) N-alkoxyalkylamide von hydroxysauren und sie enthaltende hautbehandlungszubereitungen.
ZA899113B (en) Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
DK50987A (da) Polypeptid med plasminogenaktivatorvirkning
IL82654A0 (en) Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon
EP0180737A3 (en) Use of preparations containing gamma-interferon (ifn-gamma) for treating rheumatic diseases
EP0276120A3 (en) Treatment of certain leukemias with a combination of gamma interferon and alpha interferon
EP0267684A3 (en) Human leukocyte interferon composition and skin treatment
EP0278715A3 (fr) Utilisation d'interféron gamma humain pour le traitement du carcinome de cellules basales
EP0381584A3 (fr) Utilisation de certains interférons gamma pour le traitement du cancer de l'ovaire
CS434488A1 (en) Connection of make and break control pulses' source for disconnectable gto thyristors